Good adherence to HIV treatment, undetectable viral load, reduce the risk of anal infection with high-risk HPV types for MSM with HIV
Increasing diversity of sexual experience – major UK study
Early ART only increases TB IRIS risk for people with HIV who have a CD4 cell count below 50
Multi-disease prevention campaigns (part 2): case studies from Kenya and Uganda
Rifampicin dose can be increased safely in TB treatment, may shorten duration
Another negative result in the quest for a shorter TB treatment course
Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk
